UNSPSC 51391709: Carbuterol

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0N12JR32MR. European Medicines Agency schedules Carbuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06621MIG. Carbuterol generally arises in the molecular formula C13H21N3O3.

UNSPSC 51391709 Carbuterol, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, which solicits naloxone and safe drug deactivation systems—emergency response and substance-abuse mitigation supplies—not carbuterol, a bronchodilator pharmaceutical used in respiratory treatment. The mismatch suggests either a data-classification error in the source records or a miscoding of the opportunity within the procurement system.

Seminole County's July 2026 IFB requested 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. The county required electronic bid submission, E-Verify compliance, drug-free workplace certification, and standard commercial general liability and workers' compensation insurance, with potential FEMA funding introducing federal environmental compliance obligations. No other state or local opportunities under the carbuterol code appear in the recent record. Given the absence of relevant solicitations and the material scope mismatch in the single tagged opportunity, this code shows little actionable procurement activity for vendors supplying carbuterol or related respiratory pharmaceuticals to state and local buyers.